Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.719
+0.019 (0.40%)
At close: Jun 27, 2025, 4:00 PM
4.700
-0.019 (-0.40%)
After-hours: Jun 27, 2025, 4:00 PM EDT
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $36.53 million as of June 27, 2025. Its market cap has increased by 294.77% in one year.
Market Cap
36.53M
Enterprise Value
11.99M
1-Year Change
294.77%
Ranking
Category
Stock Price
$4.72
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $36.53M, a decrease of -49.86%. That is a compound annual growth rate of -17.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 33.99M | 4.34% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.09B |
| Johnson & Johnson | 367.31B |
| AbbVie | 328.13B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 274.57B |
| Abbott Laboratories | 238.32B |
| Novartis AG | 231.01B |
| AstraZeneca | 218.32B |